141 related articles for article (PubMed ID: 29671245)
21. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
22. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
[TBL] [Abstract][Full Text] [Related]
23. Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients.
Tao T; Ma X; Yang J; Zou JY; Ji SM; Tan YS; Gong W; Du F; Xu J; Ye CM; Tang XW; Wu DP; Xue SL
Blood Cancer J; 2015 Apr; 5(4):e308. PubMed ID: 25885428
[No Abstract] [Full Text] [Related]
24. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
25. Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation.
McDuffee E; Aue G; Cook L; Ramos-Delgado C; Shalabi R; Worthy T; Vo P; Childs RW
Bone Marrow Transplant; 2017 May; 52(5):759-761. PubMed ID: 28067871
[No Abstract] [Full Text] [Related]
26. Transient proliferation of donor-derived ATL cell-like lymphocytes early after allogeneic stem cell transplantation in an adult T-cell leukemia/lymphoma patient.
Taguchi M; Imaizumi Y; Taguchi J; Imanishi D; Sasaki D; Hasegawa H; Tsushima H; Hata T; Miyazaki Y
Blood; 2013 May; 121(21):4428-30. PubMed ID: 23704050
[No Abstract] [Full Text] [Related]
27. Successful treatment of steroid-refractory gastrointestinal acute graft-versus-host disease with adjuvant vedolizumab therapy in a pediatric allogeneic stem cell transplant recipient.
Pai V; Abu-Arja R; Auletta JJ; Rangarajan HG
Pediatr Blood Cancer; 2020 Aug; 67(8):e28298. PubMed ID: 32472970
[No Abstract] [Full Text] [Related]
28. Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
Tan J; Wang Y; Yu SJ; Ma YY; Lei HY; Liu QF
Leuk Res; 2017 Aug; 59():1-7. PubMed ID: 28527401
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma.
Fukushima T; Miyazaki Y; Honda S; Kawano F; Moriuchi Y; Masuda M; Tanosaki R; Utsunomiya A; Uike N; Yoshida S; Okamura J; Tomonaga M
Leukemia; 2005 May; 19(5):829-34. PubMed ID: 15744352
[TBL] [Abstract][Full Text] [Related]
30. Ex Vivo CD34
Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
[TBL] [Abstract][Full Text] [Related]
31. Memory T cells: A helpful guard for allogeneic hematopoietic stem cell transplantation without causing graft-versus-host disease.
Huang W; Chao NJ
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):211-219. PubMed ID: 28636890
[TBL] [Abstract][Full Text] [Related]
32. Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey.
Kato K; Choi I; Wake A; Uike N; Taniguchi S; Moriuchi Y; Miyazaki Y; Nakamae H; Oku E; Murata M; Eto T; Akashi K; Sakamaki H; Kato K; Suzuki R; Yamanaka T; Utsunomiya A
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1968-74. PubMed ID: 25172635
[TBL] [Abstract][Full Text] [Related]
33. Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab?
Schneidewind L; Neumann T; Knoll F; Zimmermann K; Smola S; Schmidt CA; Krüger W
Acta Haematol; 2017; 138(1):3-9. PubMed ID: 28591758
[TBL] [Abstract][Full Text] [Related]
34. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
[TBL] [Abstract][Full Text] [Related]
35. Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.
Kumar AJ; Hexner EO; Frey NV; Luger SM; Loren AW; Reshef R; Boyer J; Smith J; Stadtmauer EA; Levine BL; June CH; Porter DL; Goldstein SC
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1094-101. PubMed ID: 23635453
[TBL] [Abstract][Full Text] [Related]
36. Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study.
Fujiwara H; Fuji S; Wake A; Kato K; Takatsuka Y; Fukuda T; Taguchi J; Uchida N; Miyamoto T; Hidaka M; Miyazaki Y; Tomoyose T; Onizuka M; Takanashi M; Ichinohe T; Atsuta Y; Utsunomiya A;
Bone Marrow Transplant; 2017 Mar; 52(3):484-488. PubMed ID: 28067877
[No Abstract] [Full Text] [Related]
37. Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study.
Hirosawa M; Goto M; Oku M; Akao K; Kitamura N; Nakanishi T; Tanaka A; Niino D; Higashi T; Morimoto H; Tsukada J
Int J Hematol; 2023 Jan; 117(1):143-148. PubMed ID: 36083572
[TBL] [Abstract][Full Text] [Related]
38. Eosinophils from hematopoietic stem cell recipients suppress allogeneic T cell proliferation.
Andersson J; Cromvik J; Ingelsten M; Lingblom C; Andersson K; Johansson JE; Wennerås C
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1891-8. PubMed ID: 25175795
[TBL] [Abstract][Full Text] [Related]
39. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.
Winsett FT; Lewis DJ; Duvic M
Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726
[TBL] [Abstract][Full Text] [Related]
40. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
Utsunomiya A
Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
